Skip to main content
. 2020 Oct 14;10:17293. doi: 10.1038/s41598-020-74195-6

Figure 6.

Figure 6

LRRK2 kinase inhibitor exposure restored mtDNA damage to basal levels. (A) 24 h treatment with RA334 (1 μM) reversed mtDNA damage in LRRK2 G2019S-patient derived LCLs. (B) mtDNA copy number does not change with LRRK2 G2019S mutation or treatment. The PCR-based assay was performed in technical triplicate for each biological replicate. (*p < 0.001, determined by one-way ANOVA with a Tukey’s post-hoc comparison). n = 3 biological replicates (6 cell lines total), each performed in technical replicate. Data are presented as mean ± SEM.